Latest AstraZeneca News & Updates

See the latest news and media coverage for AstraZeneca. We track all announcements, press releases, and industry mentions in real time, all in one place.

AstraZeneca

Science-led biopharmaceutical company

astrazeneca.com

Headquarters: Cambridge, United Kingdom
Company type: Public company
Number of employees: 75,000+

Last updated Today

Latest news about AstraZeneca

In short: AstraZeneca advanced its clinical pipeline in obesity and oncology, securing several FDA approvals while expanding its manufacturing and R&D presence.

Company announcements

June 2 AstraZeneca

AstraZeneca's camizestrant delayed progression by 55% in breast cancer trial

The Phase III SERENA-6 trial also showed a 37% reduction in risk of second progression and 51% of patients achieved total ctDNA clearance.

June 1 AstraZeneca

AstraZeneca shows 30% PFS risk reduction in EMERALD-3

In EMERALD‑3 Phase III, STRIDE plus lenvatinib and TACE improved median PFS to 13.0 months versus 9.8 months and showed a positive OS trend.

May 28 AstraZeneca

AstraZeneca's Imfinzi approved in US for early bladder cancer

First immunotherapy combo for BCG-naïve high-risk NMIBC, reducing recurrence risk by 32%.

May 22 AstraZeneca

AstraZeneca's Datroway approved in US for first-line triple-negative breast cancer

First TROP2-directed ADC to show overall survival benefit in this setting, with median OS of about two years.

Media coverage

Yesterday Insider Monkey

AstraZeneca (AZN) Advances Oral GLP-1 Receptor Agonist Elecoglipron to Phase III Trials - Insider Monkey

AstraZeneca (NYSE:AZN) is one of the 12 Best Growth Stocks Trading in Oversold Territory.

June 16 KUTV

How AstraZeneca’s $50 billion investment is shaping the future of medicine

KUTV CBS 2 provides local news, weather forecasts, traffic updates, notices of events and items of interest in the community, sports and entertainment programming for...

June 15 Morningstar

LONDON BRIEFING: Astra gets FDA nod; Frasers bids for Accent Group

(Alliance News) - AstraZeneca wins US FDA priority review for kidney drug, while Frasers Group launches a GBP166 million bid for Australian retailer Accent Group...

June 15 Yahoo Finance

FDA Accepts AstraZeneca s Filing for Expanded Use of Ultomiris

AstraZeneca AZN announced that the FDA has accepted a regulatory filing seeking to expand the use of...

Never miss news about AstraZeneca

Track AstraZeneca and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

AstraZeneca competitors & trending companies

Browse news for competitors to AstraZeneca and other trending companies.